Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors

被引:88
作者
Dahlén, A [1 ]
Debiec-Rychter, M
Pedeutour, F
Domanski, HA
Höglund, M
Bauer, HCF
Rydholm, A
Sciot, R
Mandahl, N
Mertens, F
机构
[1] Univ Hosp, Dept Clin Genet, SE-22185 Lund, Sweden
[2] Univ Leuven, Ctr Human Genet, Louvain, Belgium
[3] Hop lArchet, Genet Lab, Nice, France
[4] Univ Hosp, Dept Pathol & Cytol, Lund, Sweden
[5] Karolinska Hosp, Dept Orthoped, Stockholm, Sweden
[6] Univ Leuven, Dept Pathol, Louvain, Belgium
关键词
lipoma; chromosome; 13; deletion; fluorescence in situ hybridization; cytogenetics; COLLABORATIVE STUDY-GROUP; ADIPOSE-TISSUE TUMORS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; DISTINCT REGIONS; SPINDLE-CELL; GENE; HETEROZYGOSITY; RETINOBLASTOMA; 13Q14;
D O I
10.1002/ijc.10864
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Deletions and structural rearrangements of the long arm of chromosome 13 are frequently observed in benign and low-malignant lipomatous tumors, but nothing is known about their molecular genetic consequences. We assessed the karyotypes of 40 new and 22 previously published cases (35 ordinary lipomas, IS spindle cell/pleomorphic lipomas, 2 myxolipomas, I angiomyxolipoma and 9 atypical lipomatous tumors) with chromosome 13-abnormalities, and found bands 13q 12-22 to be frequently affected. Twenty-seven cases with structural abnormalities within this region were selected for breakpoint and deletion mapping by metaphase fluorescence in situ hybridization (FISH), using a set of 20 probes. Deletions were found in 23 of 27 cases. The remaining 4 cases had seemingly balanced rearrangements. The breakpoints were scattered but clustered to band 13q 14, and in all cases with unbalanced abnormalities, a limited region within band 13q 14 was partially or completely deleted. A deletion within band 13q 14 was found together with a breakpoint on the other homologue in 5 cases, 4 of which could be tested further with regard to the status of the retinoblastoma (RBI)-gene. In all 4 cases, only I copy of the gene was deleted. In addition to the breaks and deletions in the vicinity of the RBI-locus, several other regions of 13q were recurrently affected, e.g., in the vicinity of the hereditary breast cancer (BRCA2; 13q 12)- and lipoma HMGIC fusion partner (LHFP; 13q13)- genes. Our findings strongly indicate that deletion of a limited region (similar to2.5 Mbp) within 13q 14, distal to the RBI-locus, is of importance in the development of a subset of lipomatous tumors. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:616 / 623
页数:8
相关论文
共 37 条
  • [11] The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells
    Gisselsson, D
    Höglund, M
    Mertens, F
    Johansson, B
    Dal Cin, P
    Van den Berghe, H
    Earnshaw, WC
    Mitelman, F
    Mandahl, N
    [J]. HUMAN GENETICS, 1999, 104 (04) : 315 - 325
  • [12] ISOLATION AND CHARACTERIZATION OF RADIATION HYBRIDS FOR HUMAN-CHROMOSOME-12
    HOGLUND, M
    SIDEN, T
    AMAN, P
    MANDAHL, N
    MITELMAN, F
    [J]. CYTOGENETICS AND CELL GENETICS, 1995, 69 (3-4): : 240 - 245
  • [13] JOHANSSON F, MITELMAN DATABASE CH
  • [14] Cancer epigenetics comes of age
    Jones, PA
    Laird, PW
    [J]. NATURE GENETICS, 1999, 21 (02) : 163 - 167
  • [15] PATTERNS OF LOSS OF HETEROZYGOSITY AT LOCI FROM CHROMOSOME ARM 13Q SUGGEST A POSSIBLE INVOLVEMENT OF BRCA2 IN SPORADIC BREAST-TUMORS
    KERANGUEVEN, F
    ALLIONE, F
    NOGUCHI, T
    ADELAIDE, J
    SOBOL, H
    JACQUEMIER, J
    BIRNBAUM, D
    [J]. GENES CHROMOSOMES & CANCER, 1995, 13 (04) : 291 - 294
  • [16] Hereditary retinoblastoma, lipoma, and second primary cancers
    Li, FP
    Abramson, DH
    Tarone, RE
    Kleinerman, RA
    Fraumeni, JF
    Boice, JD
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01) : 83 - 84
  • [17] Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: Identification of three independent regions
    Lin, YW
    Sheu, JC
    Liu, LY
    Chen, CH
    Lee, HS
    Huang, GT
    Wang, JT
    Lee, PH
    Lu, FJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (12) : 1730 - 1734
  • [18] Maestro R, 1996, CANCER RES, V56, P1146
  • [19] Mandahl N, 1996, INT J CANCER, V67, P632, DOI 10.1002/(SICI)1097-0215(19960904)67:5<632::AID-IJC7>3.0.CO
  • [20] 2-V